DOI: https://doi.org/10.22141/2224-0551.6.57.2014.75710

Nasopharyngeal Carriage of Streptococcus Pneumoniae in Inmates of Children’s Homes: Serotype Repertoire and Susceptibility to Antimicrobial Agents

L.I. Chernyshova, A.M. Gilfanova, A.V. Bondarenko, V.V. Yanovska, T.G. Glushkevych

Abstract


The article presents the results of the first in Ukraine investigation on the prevalence of nasopharyngeal pneumococcus carriage in healthy children up to 5 years, living in children’s homes. It is shown that the children of this cohort reported almost total nasopharyngeal colonization with pneumococcus (95.6 %). Serotypes 19F (54.8 %), 6A/B (22.5 %), 14 (4.8 %) and 23F (3.2 %) have dominated. High resistance of pneumococcus to antimicrobial agents was shown.

Keywords


nasopharyngeal carriage; pneumococcus; children’s home.

References


O’Brien K.L., Wolfson L.J., Watt J.P. et al. Hib and Pneumococcal Global Burden of Disease Study Team. Burden of disease caused by Streptococcus pneumonia in children younger than 5 years: global estimates // Lancet. — 2009. — Vol. 379. — Р. 893-902.

World Health Organization and UNICEF. Global immunization data. October 2012. Available at: http://www.who.int/immunization_monitoring/Global_Immunization_Data.pdf.p.2. Accessed February 4, 2013.

Dagan R. New insights on pneumococcal disease: What we have learned over the past decade // Vaccine. — 2009. — № 27. — Р. 3-5.

Farha T., Thomson A.H. The burden of pneumonia in children in the developed world // Paediatr. Respir. Rev. — 2005. — № 6(2). — Р. 76-82.

CDC. Prevention of Pneumococcal Disease Among Infants and Children — Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP) // MMWR. — 2010. — № 59 (No. RR-11). Available at http://www.cdc.gov

O’Brien K.L., Nohynek H. World Health Organization Pneumococcal Vaccine Trials Carriage Working Group. Report from a WHO Working Group: standard method for detecting upper respiratory carriage of Streptococcus pneumonia // The Pediatric Infectious Disease Journal. — 2003. — Vol. 22. — P. e1-11.

Bogaert D., De Groot R., Hermans P.W. Streptococcus pneumoniacolonization: the key to pneumococcal disease // Lancet Infectious Disease. — 2004. — № 4. — Р. 144-154.

Taketo Otsuka, Bin Chang et al. Individual Risk Factors Associated With Nasopharyngeal Colonization With Streptococcus pneumonia and Haemophilus influenza: A Japanese Birth Cohort Study // The Pediatric Infectious Disease Journal. — 2013. — Vol. 32. — № 7. — P. 709-714.

World Health Organization. Pneumococcal vaccines WHO position paper — 2012 // Weekly epidemiological record. — 2012. — Vol. 87. — № 14. — P. 129-144.

Tzanakaki G., Mastrantonio P. Aetiology of bacterial meningitis and resistance to antibiotics of causative pathogens in Europe and in the Mediterranean region // Int. J. Antimicrob. Agents. — 2007. — № 29(6). — Р. 621-629.

Tyrrell G.J., Lovgren M., Chui N., Minion J., Garg S., Kellner J.D. et al. Serotypes and antimicrobial susceptibilities of invasive Streptococcus pneumoniae pre- and post-seven valent pneumococcal conjugate vaccine introduction in Alberta, Canada, 2000–2006 // Vaccine. — 2009. — № 27. — Р. 3553-3560.

Stancil J.M., Peters T.R., Givner L.B., Poehling K.A. Potential Impact of Accelerating the Primary Dose of Pneumococcal Conjugate Vaccine in Infants // Arch. Pediatr. Adolesc. Med. — 2009. — № 163(5). — Р. 422-425.

Soley C., Arguedas A. Understanding the link between pneumococcal serotypes and invasive disease // Vaccine. — 2009. — № 27. — Р. 19-21.

Kadioglu A., Weiser J.N., Paton J.C., Andrew P.W. The role of Streptococcus pneumoniae virulence factors in host respiratory colonization and disease // Nat. Rev. Microbiol. — 2008. — № 6(4). — Р. 288-301.

Fleming-Dutra K.E., Congil L. et al. Systematic Review of the Effect of Pneumococcal Conjugate Vaccine Dosing Schedules on Vaccine-type Nasopharyngeal Carriage // The Pediatric Infectious Disease Journal. — 2014. — Vol. 33. — № 1. — P. 152-160.

Ray G.T., Pelton S.I., Klugman K.P. et al. Cost-effectiveness of pnrumococcal conjugate vaccine: an update after 7 years of use in the United States // Vaccine. — 2009. — № 27. — P. 6483-6494.

Rodgers G.L., Arguedas A., Cohen R., Dagan R. Global serotype distribution among S.pneumonia isolates causing otitis media in children: potential implications for pneumococcal conjugate vaccines // Vaccine. — 2009. — № 27. — С. 3802-3810.

Techasaensiri C., Messina A.F., Katz K., Ahmad N., Huang R., McCracken G.H., Jr. Epidemiology and evolution of invasive pneumococcal disease caused by multidrug resistant serotypes of 19A in the 8 years after implementation of pneumococcal conjugate vaccine immunizationin Dallas, Texas // Pediatr. Infect. Dis. J. — 2010. — № 29(4). — С. 294-300.

Miller E., Andrews N.J., Waight P.A., Slack M.P., George R.C. Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in Englandand Wales: an observational cohort study // Lancet Infect. Dis. — 2011. — № 11(10). — Р. 760-768.

Маянский А.Н. Стрептококки: микробиология и патология // Вопросы диагностики в педиатрии. — 2010. — № 1. — С. 9-19.




Copyright (c) 2016 CHILD`S HEALTH

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

 

© Publishing House Zaslavsky, 1997-2018

 

   Seo анализ сайта